Document Detail


Role of progestins in contraception.
MedLine Citation:
PMID:  15715527     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Progestins have been used for contraception for more than 30 years. The main goal was to develop a contraceptive method devoid of the metabolic or clinical side-effects associated with the use of estrogens. The development of new contraceptive methods and formulations is time-consuming and requires devotion, belief, and also strong economical basis. As a result of this endeavor new methods have been developed: oral progestins, implants, injectables, intrauterine hormonal systems, and vaginal rings. Progestin-only contraceptives may be preferable in some situations, which have absolute or relative contraindications to estrogen, side-effects to estrogen containing hormonal contraception, lactation, and comfort and feasibility of formulations for long-term use. At present, emergency contraception is also performed with progestin.
Authors:
Risto Erkkola; Britt-Marie Landgren
Related Documents :
18372257 - The cost-effectiveness of long-acting reversible contraceptive methods in the uk: analy...
8200877 - The effect of price increases on contraceptive sales in bangladesh.
3318467 - Updated pregnancy rates for the today contraceptive sponge.
16281297 - Pregnancy in dystonic women with in situ deep brain stimulators.
23312717 - A viable foal obtained by equine somatic cell nuclear transfer using oocytes recovered ...
2910377 - Diurnal variation in admission to hospital of women in labour.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Acta obstetricia et gynecologica Scandinavica     Volume:  84     ISSN:  0001-6349     ISO Abbreviation:  Acta Obstet Gynecol Scand     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-02-17     Completed Date:  2005-03-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370343     Medline TA:  Acta Obstet Gynecol Scand     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  207-16     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, University Central Hospital, Turku, Finland. risto.erkkola@tyks.fi
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cervix Mucus / drug effects
Contraception / methods*
Contraceptive Agents, Female / adverse effects,  pharmacology*
Contraceptive Devices, Female*
Contraceptives, Oral
Contraceptives, Oral, Combined
Drug Implants
Endometrium / drug effects
Fallopian Tubes / drug effects
Female
Humans
Intrauterine Devices
Ovulation / drug effects
Progesterone Congeners / adverse effects,  pharmacology*,  physiology
Reproductive Control Agents / administration & dosage,  adverse effects
Chemical
Reg. No./Substance:
0/Contraceptive Agents, Female; 0/Contraceptives, Oral; 0/Contraceptives, Oral, Combined; 0/Drug Implants; 0/Progesterone Congeners; 0/Reproductive Control Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Application of RNA interference to study stem cell function: current status and future perspectives.
Next Document:  Normal labor associated with changes in uterine heparan sulfate proteoglycan expression and localiza...